We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Coronary Clot Aspiration Provides No MI Survival Benefit

By HospiMedica International staff writers
Posted on 02 Feb 2016
Print article
Thrombectomy did not improve outcomes for myocardial infarct (MI) patients presenting after symptom onset, according to a new study.

Researchers at University College London (UCL; United Kingdom), the University of Manchester (United Kingdom), and other institutions conducted a retrospective study based on a UK national registry to examine thrombectomy use in ST-segment elevation MI (STEMI) patients and relationship to overall mortality. In all, 98,176 patients treated via percutaneous coronary intervention (PCI) were grouped on the basis of whether they received thrombectomy or not; subgroups of simple (manual aspiration) and complex (mechanical) thrombectomy were also evaluated.

The results showed no significant mortality difference between the overall thrombectomy group and the no thrombectomy group, either at 30 days or at one year. Likewise, no difference was seen between the simple thrombectomy versus no thrombectomy. The complex thrombectomy group, on the other hand, demonstrated significantly higher mortality at one-year follow-up. The researchers observed that thrombectomy use markedly increased in the United Kingdom between 2008 and 2010, but plateaued thereafter at slightly below 50% of all primary PCI cases. The study was published in the January 2016 issue of JACC: Cardiovascular Interventions.

“Our large observational study does not provide evidence to support the hypothesis that selective thrombectomy in primary PCI is associated with lower mortality,” concluded lead author Alex Sirker, MB BChir, and colleagues. “Our findings are in keeping with other negative clinical outcomes from two recent large randomized controlled trials studying routine thrombectomy use in STEMI.”

“Thrombus removal remains an intuitively valid concept; however, thrombus removal is more complex than initially appreciated,” added Dharam Kumbhani, MD, of the University of Texas Southwestern Medical Center (Dallas, USA) and Anthony Bavry, MD, of the University of Florida, (Gainesville, USA), in a related editorial. “Future studies will need to similarly rigorously evaluate the role of selective thrombectomy versus no thrombectomy, determine more effective thrombectomy devices, and better discriminate appropriate lesions to which this therapy can be applied.”

Thrombectomy with aspiration of thrombus prior to PCI is thought to prevent distal embolization and improve microvascular perfusion. But although electrocardiographic and angiographic outcomes improve with thrombectomy, such as an increased ST-segment resolution and a decreased distal embolization, no clinical benefits have been shown. One recent large study even found that the risk of stroke actually increased by 66%.

Related Links:

University College London
University of Manchester


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
LED Surgical Light
Convelar 1670 LED+/1675 LED+/1677 LED+
New
Electric Cast Saw
CC4 System

Print article

Channels

Critical Care

view channel
Image: The BrioVAD System featuring the innovative BrioVAD Pump (Photo courtesy of BrioHealth Solutions)

Innovative Ventricular Assist Device Provides Long-Term Support for Advanced Heart Failure Patients

Advanced heart failure represents the final stages of heart failure, where the heart’s ability to pump blood effectively is severely compromised. This condition often results from underlying health issues... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.